During an episode of CRN's Supplement Source Podcast, President and CEO Steve Mister of the Council for Responsible Nutrition discussed the trade association's "We Are Responsible" campaign and how the focus on self-regulation sets CRN members apart.
Listen here:
Barnes brings extensive health care management experience to the company.
CRN cautions that misinterpretation of the recommendations as broadly advising against supplementation could lead to the dismissal of other health benefits associated with these essential nutrients.
Erlotinib tablets are a kinase inhibitor indicated for the treatment of patients with metastatic non-small cell lung cancer (NSCLC).
Quincy Bioscience, the dietary supplement maker, must stop making specific advertising claims deemed deceptive.
Congress fumbled a chance to rein in big insurance and PBMs and save taxpayers billions, says NCPA.
CRN calls for a science-driven FDA strategy, highlighting extensive research backing dietary supplements.
PQA Health Equity Technical Expert Panel recommendations inform measure testing, use in quality programs, and risk adjustment models.
Company no longer anticipates closing previously announced sale to Nexus Capital Management.
